CPSM: an R package for cancer patient survival risk model using transcriptomics and clinical data.

IF 5 2区 生物学 Q1 MULTIDISCIPLINARY SCIENCES
Harpreet Kaur, Pijush Das, Kevin Camphausen, Uma Shankavaram
{"title":"CPSM: an R package for cancer patient survival risk model using transcriptomics and clinical data.","authors":"Harpreet Kaur, Pijush Das, Kevin Camphausen, Uma Shankavaram","doi":"10.1093/gigascience/giag067","DOIUrl":null,"url":null,"abstract":"<p><p>Traditional Kaplan-Meier curves capture aggregate survival trends within broad patient subgroups but overlook the heterogeneity of individual patients. In contrast, single-patient survival risk models bridge this gap by incorporating each patient's unique clinical, genomic, and demographic characteristics, generating personalized survival curves. These individualized visualizations enhance patient-clinician communication by translating complex statistics into intuitive, time-based visuals that are easier to interpret. However, the complexity, high dimensionality, and heterogeneity of multiomics data present significant challenges for analysis, interpretation, and model development. To address these challenges, we introduce the Cancer Patient Survival Model (CPSM), an R package designed to deliver individualized survival and risk predictions through a fully integrated, reproducible computational pipeline. CPSM includes 10 core functions organized into 4 key steps: (i) data preprocessing and normalization, (ii) feature selection, (iii) survival risk group prediction modeling, and (iv) visualization and nomogram construction. We demonstrate the utility of CPSM using publicly available datasets from The Cancer Genome Atlas for 4 cancer types: glioblastoma multiforme (GBM), acute myeloid leukemia (LAML), pancreatic adenocarcinoma (PAAD), and breast invasive cancer (BRCA). CPSM efficiently handles high-dimensional datasets with over 60,000 RNA transcripts and diverse clinical variables, enabling robust and interpretable individualized survival predictions under varying data conditions. Model performance was evaluated using repeated cross-validation with uncertainty quantification, ensuring robust and reliable estimates in high-dimensional, small-sample settings. In summary, CPSM provides an efficient, user-friendly, end-to-end solution for integrating patient data and generating personalized survival and risk predictions. Its integrated visual tools enhance interpretability and support more informed clinical decision-making. The package is freely available on Bioconductor (https://bioconductor.org/packages/devel/bioc/html/CPSM.html) and GitHub (https://github.com/hks5august/CPSM).</p>","PeriodicalId":12581,"journal":{"name":"GigaScience","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13289734/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GigaScience","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/gigascience/giag067","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Traditional Kaplan-Meier curves capture aggregate survival trends within broad patient subgroups but overlook the heterogeneity of individual patients. In contrast, single-patient survival risk models bridge this gap by incorporating each patient's unique clinical, genomic, and demographic characteristics, generating personalized survival curves. These individualized visualizations enhance patient-clinician communication by translating complex statistics into intuitive, time-based visuals that are easier to interpret. However, the complexity, high dimensionality, and heterogeneity of multiomics data present significant challenges for analysis, interpretation, and model development. To address these challenges, we introduce the Cancer Patient Survival Model (CPSM), an R package designed to deliver individualized survival and risk predictions through a fully integrated, reproducible computational pipeline. CPSM includes 10 core functions organized into 4 key steps: (i) data preprocessing and normalization, (ii) feature selection, (iii) survival risk group prediction modeling, and (iv) visualization and nomogram construction. We demonstrate the utility of CPSM using publicly available datasets from The Cancer Genome Atlas for 4 cancer types: glioblastoma multiforme (GBM), acute myeloid leukemia (LAML), pancreatic adenocarcinoma (PAAD), and breast invasive cancer (BRCA). CPSM efficiently handles high-dimensional datasets with over 60,000 RNA transcripts and diverse clinical variables, enabling robust and interpretable individualized survival predictions under varying data conditions. Model performance was evaluated using repeated cross-validation with uncertainty quantification, ensuring robust and reliable estimates in high-dimensional, small-sample settings. In summary, CPSM provides an efficient, user-friendly, end-to-end solution for integrating patient data and generating personalized survival and risk predictions. Its integrated visual tools enhance interpretability and support more informed clinical decision-making. The package is freely available on Bioconductor (https://bioconductor.org/packages/devel/bioc/html/CPSM.html) and GitHub (https://github.com/hks5august/CPSM).

CPSM:基于转录组学和临床数据的癌症患者生存风险模型R包。
传统的Kaplan-Meier曲线捕获了广泛患者亚组内的总体生存趋势,但忽略了个体患者的异质性。相比之下,单个患者生存风险模型通过结合每个患者独特的临床、基因组和人口统计学特征,生成个性化的生存曲线,弥补了这一差距。这些个性化的可视化通过将复杂的统计数据转化为更容易解释的直观的、基于时间的视觉效果,增强了患者与临床医生的沟通。然而,多组学数据的复杂性、高维性和异质性为分析、解释和模型开发带来了重大挑战。为了应对这些挑战,我们推出了癌症患者生存模型(CPSM),这是一个R包,旨在通过完全集成的、可重复的计算管道提供个性化的生存和风险预测。CPSM包括10个核心功能,分为4个关键步骤:(1)数据预处理和归一化,(2)特征选择,(3)生存风险组预测建模,(4)可视化和Nomogram构建。我们利用公开可用的TCGA数据集证明了CPSM在四种癌症类型中的应用:多形胶质母细胞瘤(GBM)、急性髓性白血病(LAML)、胰腺腺癌(PAAD)和乳腺浸润性癌(BRCA)。CPSM有效地处理具有超过60,000个RNA转录本和多种临床变量的高维数据集,在不同的数据条件下实现稳健和可解释的个性化生存预测。模型性能评估使用重复交叉验证和不确定度量化,确保在高维,小样本设置稳健和可靠的估计。总之,CPSM提供了一种高效、用户友好的端到端解决方案,用于整合患者数据并生成个性化的生存和风险预测。其集成的可视化工具增强了可解释性,并支持更明智的临床决策。该软件包可在Bioconductor (https://bioconductor.org/packages/devel/bioc/html/CPSM.html)和GitHub (https://github.com/hks5august/CPSM)上免费获得。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
GigaScience
GigaScience MULTIDISCIPLINARY SCIENCES-
CiteScore
15.50
自引率
1.10%
发文量
119
审稿时长
1 weeks
期刊介绍: GigaScience seeks to transform data dissemination and utilization in the life and biomedical sciences. As an online open-access open-data journal, it specializes in publishing "big-data" studies encompassing various fields. Its scope includes not only "omic" type data and the fields of high-throughput biology currently serviced by large public repositories, but also the growing range of more difficult-to-access data, such as imaging, neuroscience, ecology, cohort data, systems biology and other new types of large-scale shareable data.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书